How federal courts have been stepping in on Trump's second-term agenda
03:55
FDA pulls proposed rule banning minors from tanning beds
03:00
Jury finds Elon Musk liable for misleading investors ahead of Twitter acquisition
02:50
Trump weighing several options for U.S. troops in Iran
10:19
Epstein’s former lawyer answers questions in House deposition
03:39
Joseph Duggar of '19 Kids and Counting' accused of molesting a minor
03:42
Over a million people displaced in Lebanon as Israel expands offensive against Hezbollah
02:46
Concerns grow over minors betting as former underage gamblers speak out
05:50
ABC cancels ‘The Bachelorette’ after new video shows star assaulting ex-partner
03:09
Former FBI Director Comey subpoenaed in Trump-appointed prosecutor’s conspiracy probe
02:13
Body of missing University of Alabama student found on beach in Spain
02:03
Exploring who has the power to declare war
03:10
Japan’s new prime minister faces hurdles with delicate U.S. relations
02:19
Trump’s plan for border wall worries local residents and politicians
03:30
How the war with Iran impacts global energy supply
02:34
Students take advantage of artificial intelligence while studying for SAT
03:37
WNBA and players scramble to reach deadline on union agreement
02:54
Strong chemical smell causes ground stop at D.C. area airports
00:33
What the war in Iran means for China
03:34
Women in Hollywood face slowdown in progress seen in last few years
02:37
NBC News NOW
Popular diabetes and weight loss drugs often hard to get for people who need them
This version of Popular Diabetes And Weight Loss Drugs Often Hard To Get For People Who Need Them 206712901835 - Breaking News | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.
03:16
Copied
Exclusive data obtained by NBC News shows that popular diabetes and weight loss drugs including Wegovy and Ozempic are largely unattainable for the people who need them most with the out of pocket cost being over $1,000. More than four million prescriptions were written in 2023, and only 12% of them were for African Americans, who have significantly higher rates of diabetes and obesity.March 15, 2024
